Understanding the Otago Study's Core Findings
The University of Otago's latest research publication has cast a spotlight on a pressing issue in New Zealand's healthcare landscape: a severe shortage of neurologists. Titled Aotearoa New Zealand’s Neurologist Workforce: A 2024 Analysis of Demand, Supply and Projections, this study, led by Professor Anna Ranta from the Department of Medicine at University of Otago, Wellington, meticulously analyzes the current state and future trajectory of the neurology workforce. Published in the prestigious BMJ Neurology Open, it draws on comprehensive data to reveal that demand for neurological services far outstrips available expertise.
Neurology, the medical specialty focused on diagnosing and treating disorders of the nervous system—including the brain, spinal cord, and peripheral nerves—plays a critical role in managing conditions like stroke, multiple sclerosis (MS), Parkinson's disease, epilepsy, and Alzheimer's disease. The study highlights how New Zealand's aging population and advancements in treatments are amplifying the need for these specialists, yet systemic constraints prevent adequate response.
Researchers combined surveys from individual neurologists, public hospital unit heads, Health NZ records, and data from the Royal Australasian College of Physicians (RACP) and the Australian and New Zealand Association of Neurologists (ANZAN). This multi-source approach ensures robust validation, painting a clear picture of workforce capacity measured in full-time equivalents (FTEs), where one FTE represents a full clinical workload excluding pure academic or administrative duties.
Current Neurology Workforce Landscape in New Zealand
In 2024, New Zealand boasts 83 individual neurologists across public and private sectors, delivering 67.3 FTEs. This breaks down to 52.6 FTEs in public adult neurology, 8.3 FTEs in paediatric neurology, and 6.4 FTEs in private practice. Translated to population terms, this equates to roughly one neurologist per 74,604 people—or 1.34 per 100,000 inhabitants.
Regional disparities exacerbate the challenge. Nearly 79% of FTEs are concentrated in five tertiary centers: Auckland, Christchurch, Wellington, Hamilton, and Dunedin, yielding a ratio of 1 per 70,267 there. Secondary and regional areas fare worse at 1 per 104,859. Paediatric services, vital for conditions like epilepsy in children, are almost entirely tertiary-based.
Productivity metrics reveal strain: neurologists handle an average of 791 patient contact equivalents (PCEs) per year, down 10% from 875 in 2014. PCEs standardize diverse activities—first specialist assessments (46.5 minutes each), follow-ups (26 minutes), injections, electromyography (EMG), and admissions—allowing fair workload comparisons.
Only about one in five patients with chronic neurological diseases receives regular neurologist review, far below optimal. Health NZ data shows a 1:1 ratio of first assessments to follow-ups, whereas best practice expects 1:6, underscoring rushed discharges and limited ongoing care.
International Benchmarks and New Zealand's Position
Compared globally, New Zealand lags. Australia enjoys 1 neurologist per 41,000 people (2.77 per 100,000), while other high-income nations average 1 per 14,000 (7.1 per 100,000). A recent Australian model pegs best-practice needs at 1 per 28,000, accounting for disease prevalence and comprehensive management.
New Zealand's generalist-oriented practice—where general physicians and general practitioners (GPs) handle more primary neurological care—narrows the gap somewhat but doesn't eliminate it. Even adjusted, demand exceeds supply by 28.7 FTEs currently.
This positions New Zealand below peers, prompting calls for alignment with international standards to optimize outcomes in stroke recovery, MS management, and dementia care.
Drivers Fueling Demand Surge
New Zealand's population is aging rapidly, with neurological disorders disproportionately affecting older adults. Stroke incidence, the second-leading cause of death and disability, demands acute interventions like reperfusion therapies—clot-busting drugs or mechanical thrombectomy to restore brain blood flow within hours of onset. Telemedicine and patient transfers to specialized centers have increased, yet workforce investment hasn't matched.
Chronic conditions amplify needs: MS prevalence rises, with complex disease-modifying therapies requiring ongoing monitoring. Parkinson's affects an estimated 14,000 Kiwis, projected higher by 2030. Emerging Alzheimer's treatments, like anti-amyloid antibodies, and therapies for rare disorders such as spinal muscular atrophy and neurogenetic diseases will further strain resources.
Epidemiological models estimate 0.6% annual population needing first assessments and 3.6% under follow-up, translating to escalating PCE demands as cases grow with demographics.
Projections: A Foreseeable Crisis
Under baseline assumptions—current training (4-5 new neurologists yearly), recruitment, retention, and productivity—the gap widens. By 2036, supply reaches 76.6 FTEs against 98 FTE demand, a 46.3 FTE shortfall. Aggressive scenarios require 4.5 additional FTEs annually to match baseline or 12 FTEs for Australian benchmarks (213 FTE demand).
Annual retirements (1.7 neurologists) outpace net gains (1.3 public FTE/year historically). With 13 training posts but only 1.7 filled vacancies, excess trainees often exit to private practice or overseas.
Training Pathways and Capacity Constraints
Neurology specialist training in New Zealand follows RACP's Advanced Training program: three years full-time equivalent post-basic physician training. Accredited sites include major hospitals linked to universities like Otago and Auckland. ANZAN coordinates recruitment, with capacity for 4-5 completions annually across 13 posts.
To bridge gaps, training expansion is essential—1.2-3 additional spots yearly for baseline, up to 9 for optimal. Universities play pivotal roles: Otago offers New Zealand's sole undergraduate Neuroscience degree, fostering early interest, while its medical school and Wellington campus produce researchers like Prof. Ranta. Auckland's Centre for Brain Research drives clinical neuroscience, from genetics to therapies, supporting hospital-based training.
Challenges include attracting medical students via observerships and curricula integration, plus retaining graduates with competitive academic-clinical roles. For those eyeing neurology careers, explore higher education jobs in medical faculties or research positions at Otago and Auckland.
Patient Impacts and Real-World Examples
Shortages translate to delays and suboptimal care. A Palmerston North woman experiencing seizures found no on-call neurologist, forcing reliance on a GP consulting remotely. Chronic patients miss vital follow-ups, risking progression in MS or Parkinson's.
Equity issues loom: rural and Māori/Pasifika populations face greater barriers, compounding health disparities in neurological outcomes.
Solutions: From Policy to Innovation
The study urges strong funding for training expansion, international recruitment, and retention incentives. Diversify workforce demographics to mirror New Zealand's population (currently 32.6% female neurologists, up from 23.3% in 2014). Leverage AI for triage, diagnostics, and admin relief to boost productivity.
Universities can lead: bolster neuroscience programs, PhD pathways in brain research, and hybrid academic-clinical posts. Check clinical research jobs or career advice for pathways into neurology academia.
| Solution | Impact |
|---|---|
| Increase training posts | 1.2-9 more/year |
| Recruit internationally | Fill vacancies quickly |
| Adopt tech/AI | Enhance productivity |
| Diversify workforce | Improve access/equity |
Academic Opportunities in Neurology Research
The shortage signals demand for academic neurologists. Otago's Neurology Research Group and Auckland's brain initiatives offer lecturer/professor roles blending teaching, research, and clinics. Positions in Dunedin, Wellington, and Auckland abound for qualified specialists—view university jobs in NZ.
Prospective researchers: pursue neuroscience undergrad at Otago, then RACP training, leading to faculty posts advancing stroke genomics or MS therapies.
Photo by Markus Winkler on Unsplash
Future Outlook: Research and Systemic Change
Optimism lies in action: expanded training, tech integration, and policy shifts could align supply with needs. Otago's study provides a roadmap, urging Health NZ and government investment. For career seekers, neurology offers rewarding paths amid growth—explore higher-ed jobs, rate professors, and career advice. Ongoing university-led research promises innovations to ease the burden.
Read the full Otago study or Otago newsroom release for deeper insights. For more on NZ opportunities, visit AcademicJobs NZ section.